{"id":28082,"date":"2024-11-04T10:49:04","date_gmt":"2024-11-04T09:49:04","guid":{"rendered":"https:\/\/ggba.swiss\/perivision-receives-ce-marking-for-its-visionone-glaucoma-diagnostics-device\/"},"modified":"2024-11-04T10:50:44","modified_gmt":"2024-11-04T09:50:44","slug":"perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/","title":{"rendered":"PeriVision re\u00e7oit le marquage CE pour son dispositif de diagnostic du glaucome VisionOne"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.perivision.com\/\">PeriVision<\/a>, une spin-off de l&rsquo;<a href=\"https:\/\/www.unibe.ch\/\">Universit\u00e9 de Berne<\/a> et de l&rsquo;<a href=\"https:\/\/www.insel.ch\/fr\/\">Inselspital<\/a>, a obtenu la certification CE de l&rsquo;UE pour son appareil VisionOne, marquant ainsi une \u00e9tape importante dans l&rsquo;avancement du diagnostic du glaucome. Cette certification permet \u00e0 PeriVision de commercialiser VisionOne dans toute l&rsquo;Europe, offrant aux ophtalmologues et aux optom\u00e9tristes une solution plus efficace et portable pour tester le champ visuel. Avec plus de 80 millions de personnes touch\u00e9es par le glaucome dans le monde, VisionOne r\u00e9pond \u00e0 un besoin critique d&rsquo;outils de diagnostic am\u00e9lior\u00e9s et accessibles pour aider \u00e0 pr\u00e9venir la c\u00e9cit\u00e9 irr\u00e9versible.<\/p>\n\n\n\n<p>Le syst\u00e8me VisionOne fonctionne avec des casques VR portables et rationalise le processus d&rsquo;examen du champ visuel. Au c\u0153ur de cette technologie se trouve l&rsquo;algorithme SORS (Sequentially Optimized Reconstruction Strategy), propri\u00e9t\u00e9 de PeriVision, qui r\u00e9duit consid\u00e9rablement la dur\u00e9e des tests tout en maintenant une grande pr\u00e9cision de diagnostic. La plateforme du syst\u00e8me, bas\u00e9e sur le cloud, am\u00e9liore encore l&rsquo;exp\u00e9rience de l&rsquo;utilisateur en permettant aux cliniciens d&rsquo;analyser les r\u00e9sultats et de suivre les progr\u00e8s des patients gr\u00e2ce \u00e0 un contr\u00f4le de qualit\u00e9 automatis\u00e9 et \u00e0 des configurations de test optimis\u00e9es.<\/p>\n\n\n\n<p>La certification CE est une r\u00e9alisation majeure pour PeriVision, car elle n\u00e9cessite des tests rigoureux de s\u00e9curit\u00e9 et d&rsquo;efficacit\u00e9. Patrick Kessel, CEO de PeriVision, a soulign\u00e9 les efforts de collaboration \u00e0 l&rsquo;origine de ce succ\u00e8s : \u00ab Ce succ\u00e8s a \u00e9t\u00e9 possible gr\u00e2ce aux efforts incroyables de notre \u00e9quipe de r\u00e9glementation et au savoir-faire de nos partenaires d&rsquo;Effectum Medical. Nous sommes ravis de mettre les capacit\u00e9s de diagnostic de VisionOne \u00e0 la disposition des patients et des professionnels des soins oculaires dans toute l&rsquo;Europe. \u00bb<\/p>\n\n\n\n<p>Avec l&rsquo;obtention du marquage CE, PeriVision est en mesure d&rsquo;\u00e9tendre sa pr\u00e9sence en Europe. La soci\u00e9t\u00e9 a d\u00e9j\u00e0 sign\u00e9 des accords de distribution en Suisse, au Liechtenstein, en Espagne, en Gr\u00e8ce, \u00e0 Chypre et au Royaume-Uni, et les cliniques ont pass\u00e9 leurs premi\u00e8res commandes par l&rsquo;interm\u00e9diaire de ces canaux. PeriVision propose VisionOne selon un double mod\u00e8le commercial : un abonnement au logiciel en tant que service (SaaS) et un achat unique avec des frais de service, ce qui offre une grande flexibilit\u00e9 aux prestataires de soins ophtalmologiques.<\/p>\n\n\n\n<p>Cette certification s&rsquo;appuie sur les efforts continus de PeriVision pour transformer les diagnostics ophtalmologiques. Au d\u00e9but de l&rsquo;ann\u00e9e, <a href=\"https:\/\/ggba.swiss\/fr\/perivision-obtient-chf-11-million-pour-la-recherche-sur-les-maladies-de-la-retine\/\">PeriVision a re\u00e7u une bourse de CHF 1,1 million en collaboration avec l&rsquo;Inselspital et l&rsquo;Universit\u00e9 de Berne<\/a> pour d\u00e9velopper des tests oculaires pilot\u00e9s par l&rsquo;IA pour les maladies de la r\u00e9tine, \u00e9largissant ainsi son champ d&rsquo;action du glaucome \u00e0 des besoins ophtalmologiques plus larges.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PeriVision, une start-up bernoise, a re\u00e7u le marquage CE pour son appareil VisionOne, ce qui lui permet d&rsquo;\u00eatre vendu dans toute l&rsquo;Europe.<\/p>\n","protected":false},"author":6,"featured_media":28079,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[845],"tags":[1179,1180,1152,1181,1163],"class_list":["post-28082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech","tag-artificial-intelligence-fr-2","tag-digital-health-fr-2","tag-digital-transformation-fr","tag-medical-devices-fr","tag-medtech-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PeriVision re\u00e7oit le marquage CE pour son dispositif VisionOne<\/title>\n<meta name=\"description\" content=\"PeriVision, une start-up bernoise, a re\u00e7u le marquage CE pour son appareil VisionOne, ce qui lui permet d&#039;\u00eatre vendu dans toute l&#039;Europe.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PeriVision re\u00e7oit le marquage CE pour son dispositif VisionOne\" \/>\n<meta property=\"og:description\" content=\"PeriVision, une start-up bernoise, a re\u00e7u le marquage CE pour son appareil VisionOne, ce qui lui permet d&#039;\u00eatre vendu dans toute l&#039;Europe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-04T09:49:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-04T09:50:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"PeriVision re\u00e7oit le marquage CE pour son dispositif de diagnostic du glaucome VisionOne\",\"datePublished\":\"2024-11-04T09:49:04+00:00\",\"dateModified\":\"2024-11-04T09:50:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/\"},\"wordCount\":484,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Digital Transformation\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Tech\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/\",\"name\":\"PeriVision re\u00e7oit le marquage CE pour son dispositif VisionOne\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg\",\"datePublished\":\"2024-11-04T09:49:04+00:00\",\"dateModified\":\"2024-11-04T09:50:44+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"PeriVision, une start-up bernoise, a re\u00e7u le marquage CE pour son appareil VisionOne, ce qui lui permet d'\u00eatre vendu dans toute l'Europe.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Le dispositif VisionOne de PeriVision, qui porte le marquage CE, apporte aux cliniques europ\u00e9ennes des diagnostics avanc\u00e9s sur le glaucome, combinant la portabilit\u00e9 de la RV et l'analyse bas\u00e9e sur le cloud pour des tests de champ visuel rationalis\u00e9s. | \u00a9 PeriVision\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PeriVision re\u00e7oit le marquage CE pour son dispositif de diagnostic du glaucome VisionOne\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PeriVision re\u00e7oit le marquage CE pour son dispositif VisionOne","description":"PeriVision, une start-up bernoise, a re\u00e7u le marquage CE pour son appareil VisionOne, ce qui lui permet d'\u00eatre vendu dans toute l'Europe.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/","og_locale":"fr_FR","og_type":"article","og_title":"PeriVision re\u00e7oit le marquage CE pour son dispositif VisionOne","og_description":"PeriVision, une start-up bernoise, a re\u00e7u le marquage CE pour son appareil VisionOne, ce qui lui permet d'\u00eatre vendu dans toute l'Europe.","og_url":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-11-04T09:49:04+00:00","article_modified_time":"2024-11-04T09:50:44+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"PeriVision re\u00e7oit le marquage CE pour son dispositif de diagnostic du glaucome VisionOne","datePublished":"2024-11-04T09:49:04+00:00","dateModified":"2024-11-04T09:50:44+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/"},"wordCount":484,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg","keywords":["Artificial Intelligence","Digital Health","Digital Transformation","Medical Devices","Medtech"],"articleSection":["Tech"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/","url":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/","name":"PeriVision re\u00e7oit le marquage CE pour son dispositif VisionOne","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg","datePublished":"2024-11-04T09:49:04+00:00","dateModified":"2024-11-04T09:50:44+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"PeriVision, une start-up bernoise, a re\u00e7u le marquage CE pour son appareil VisionOne, ce qui lui permet d'\u00eatre vendu dans toute l'Europe.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Perivision-CE-MArking-1180x811-1.jpg","width":1180,"height":811,"caption":"Le dispositif VisionOne de PeriVision, qui porte le marquage CE, apporte aux cliniques europ\u00e9ennes des diagnostics avanc\u00e9s sur le glaucome, combinant la portabilit\u00e9 de la RV et l'analyse bas\u00e9e sur le cloud pour des tests de champ visuel rationalis\u00e9s. | \u00a9 PeriVision"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/perivision-recoit-le-marquage-ce-pour-son-dispositif-de-diagnostic-du-glaucome-visionone\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"PeriVision re\u00e7oit le marquage CE pour son dispositif de diagnostic du glaucome VisionOne"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/28082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=28082"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/28082\/revisions"}],"predecessor-version":[{"id":28084,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/28082\/revisions\/28084"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/28079"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=28082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=28082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=28082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}